Global Medical Director, GMA Oncology (m/f/d)

The Global Medical Director, GMA Oncology role is a unique opportunity for an experienced, innovative, and proactive medical professional to facilitate the understanding of the value of our oncology medicines, the science behind them, and the public impact they can offer. This is accomplished by developing and implementing the global medical scientific strategic plan to generate insights, shape optimal care through scientific dialogue and education, and delivering impact by generating and communicating the evidence and delivering solutions to close the gaps.The Global Medical Director, GMA Oncology asset being developed in solid tumors will work in a thriving team of medical business leaders in oncology where people will be inspired to drive towards achieving our goals of getting Ahead of Disease Together and positively impacting patient and population health outcomes globally.The role requires multi-functional matrix management, influencing major markets as well as key global functions including commercial, clinical, regulatory affairs, and health outcomes. This is an opportunity for a talented scientist who has medical affairs experience with assets in Ph 1-3 clinical development as well as approval and launch, and a track record of success to drive impactful medical affairs plans.This will be achieved through exceptional partnerships internally, and with external experts and scientific leadership to ensure seamless global to local execution on key deliverables and tactics such as: global medical strategic and operational planning, advice seeking, integrated evidence planning and execution, strategic publication planning, strategic and scientific evaluation of investigator-sponsored studies, cross-functional global task forces to support priority clinical trials, and impactful scientific communications. The successful applicant will be accountable to the Early Medical Lead, Global Medical Affairs Oncology.Key ResponsibilitiesSupport the Global Medical Lead in the development and timely execution of practice changing Global Medical Affairs Plans (MAP) and Integrated Evidence plans (IEP) in partnership with key stakeholders through the Global Medical Affairs Team (GMAT) and Integrated Evidence Team (IET).Thinks globally, while deeply understands priority LOC (Local Operating Company) needs and success measures. This is accomplished through extensive partnership and collaboration with LOC teams to understand landscape, market value drivers, unmet medical needs and timelines for deliverables required for their success.Partners across the internal ecosystem and with external partners to deliver Medical Plans that prioritize external impact above all else on time and on budget.Leveraging insights and learnings, inputs into the design of clinical trials and development plans to optimize the positive impact for patients.Drives excellence in scientific engagement by developing a strong collaborative network of global external experts (HCPs, patients, payors and regulators) to be engaged in advice seeking activities and appropriate initiatives to advance clinical care and patient outcomes in partnership with the LOC Medical teams where those experts reside.Collaborates with global external experts on investigator-initiated studies or other collaborative research initiatives.Ensures colleagues have a robust knowledge of the relevant and emerging clinical evidence, supporting their training by partnering on the creation and delivery of high-quality scientific materials for both internal and external use.Partner with Global Product Strategy, Market Access, and core country teams to support/advise on messaging and material review.Ensure appropriate medical governance oversight including management of product-related issues with potential impact on patient safety and of risk assessment and mitigation plan associated with deliverables/strategies.Development of deep subject matter expertise on the product and therapy area as well as the ability to drive proactive strategic and operational planning.Drive a culture and delivery mindset of future ready innovation which supports faster and specific solutions for patients.Qualifications & SkillsMD/MBBS/PharmD or PhD in clinical / scientific discipline.Long-standing experience in Medical Affairs.Experience working in an LOC and/or global team supporting pipeline assets in Phase 1 to 3 clinical development, and Pré/Peri and launch phases of a product’s lifecycle.Oncology work experience.Experience in medical strategic and operational planning, integrated evidence planning and execution.Experience with strategic publication planning and scientific evaluation of investigator-sponsored studies.Preferred Qualifications & SkillsPrevious clinical or scientific experience in oncology, specifically solid tumors, is strongly preferred.Demonstrated matrix leadership in previous roles with ability to build strong networks, manage complexity and cultural diversity.Demonstrated experience with development and on-time delivery of global or local medical strategies & operational plans as well as asset launches, especially within a priority market.Skilled at simultaneous consideration of scientific data and practical healthcare delivery needs from diverse health systems to optimise medical implementation of innovation.Experience in medical support for briefing documents for regulatory interactions and payor dossiers.General understanding of statistics, safety, regulatory requirements.Robust understanding of internal and external codes of practice and regulations (certification where applicable).Exceptional interpersonal, verbal, and written communication skills in English.Ability to prioritise and manage multiple projects, budgets, and interactions simultaneously and consistently produce deliverables on-time.Ability to thrive in a fast-paced, innovative environment while remaining flexible, proactive, resourceful, and efficient.Outstanding listening, communication & collaborative team working and leadership skills, as the role involves interface with a wide range of stakeholders internally and externally.Evidence of alignment to GSK Values.#J-18808-Ljbffr